SCHEMBL6574663

SCHEMBL6574663

COC(=O)NC1CC(c2ccccc2)CCN1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
OGA O60502 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
POLB P06746 3/20 0.41
ALDH1A1 P00352 2/20 0.41
CHRM4 P08173 3/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 1/20 0.41
SIGMAR1 Q99720 2/20 0.40
SLC18A3 Q16572 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GBA1 P04062 1/20 0.40
MCHR1 Q99705 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119679 0.93 SIGMAR1 (0.44) OGAHTTSMN1; SMN2CHRM4SIGMAR1
SCHEMBL5671758 0.76 KDM1A (0.49) SMN1; SMN2RAB9AKMT2A
SCHEMBL5672613 0.76 ACHE (0.54) POLBALDH1A1LMNAKMT2A
SCHEMBL6574223 0.73 MAPT (0.45) OGAHTTSMN1; SMN2POLBALDH1A1
SCHEMBL11237070 0.73 SLC18A3 (0.42) OGASMN1; SMN2ALDH1A1LMNASIGMAR1
SCHEMBL2768950 0.72 FKBP1A (0.54) POLBALDH1A1KMT2AGBA1
SCHEMBL9233648 0.72 KDM4E (0.45) SMN1; SMN2ALDH1A1LMNAKMT2AL3MBTL1
SCHEMBL6574730 0.72 SLC18A3 (0.50) OGAHTTSMN1; SMN2ALDH1A1RAB9A
SCHEMBL27393257 0.72 SIGMAR1 (0.52) SIGMAR1KMT2AGBA1
SCHEMBL18740793 0.70 ALDH1A1 (0.56) HTTSMN1; SMN2ALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409457-A1 METHOD FOR PREPARING 4-METHYLAMINO-4-PHENYLPIPERIDINE Sanofi-Aventis (FR) 2004-04-21 EP disclosed
WO-2003008381-A1 METHOD FOR PREPARING 4-METHYLAMINO-4-PHENYLPIPERIDINE SANOFI-SYNTHELABO (FR) 2003-01-30 WO disclosed